Even as schools in the United States prepares to reopen for the new school year, children account for 18% of Covid-19 infections in the country, according to recent research from the American Academy of Pediatrics (AAP). While children have accounted for 14.4% of all illnesses since the outbreak began, more than 1,21,000 youngsters in the United States tested positive for Covid-19 in the past week.
This is a 29% rise over the previous week’s total of roughly 94,000, indicating a concerning trend as the autumn semester approaches, according to the Daily Mail.
However, the infections are seldom deadly, with just 0.01 percent, or 379, dying, an increase of eight from the previous week. The American Academy of Pediatrics (AAP) has been lobbying the US Food and Drug Administration (FDA) to approve Covid-19 vaccinations for young infants.
“I write to urge the FDA to continue working vigorously toward authorizing safe and effective Covid-19 vaccinations for children under the age of 12 as soon as possible,” Dr. Lee Savio Beers, president of the American Academy of Pediatrics, said in an open letter to the FDA on August 5.
“Pediatricians and the families they serve have been eagerly anticipating a vaccination that can be used in children 11 years of age and below, especially with the emergence of the super infectious Delta variant,” she noted. Infections from the Delta form of Covid-19 are on the rise in the United States, even necessitating hospitalization, while immunization rates lag.
According to the Centers for Disease Control and Prevention, at least 81 children in the United States died from Covid between March and July, and many physicians fear that the situation is likely to worsen. According to the AAP, children are now making up a larger proportion of cases in several states.
Children account for 21% of cases in Alaska, whereas Florida (9% of total cases) is the only state where children account for less than 10% of all cases. Children have also been infected with Covid in Arkansas, Missouri, Houston, and Louisiana. Only the Pfizer-BioNTech vaccine is now approved for emergency use in children aged 12 and up. Pfizer, Moderna, and Johnson & Johnson are undertaking clinical trials to assess the vaccines’ safety and effectiveness in children under the age of 12.
(News – The Statesman)